Mode
Text Size
Log in / Sign up
N/A Completed N=64 Randomized Double-blind Treatment

Performance Comparison Between Fanfilcon A and Senofilcon A Sphere Lenses

Source: ClinicalTrials.gov NCT02956460 ↗
Enrolled (actual)
64
Serious AEs
0.0%
Results posted
Dec 2017
Primary outcomePrimary: Overall Comfort — 8.4; 8.7 units on a scale

Summary

Prospective, multi-center, bilateral, double-masked, randomized, cross-over, daily wear, 1 month dispensing study (2 weeks each lens pair)

Outcome Measures

OutcomeResultp-value
PRIMARY
Overall Comfort
8.4; 8.7
PRIMARY
Overall Dryness
8.2; 8.2
PRIMARY
Vision Quality
9.0; 8.9
PRIMARY
Lens Handling
9.3; 9.4; 8.4; 9.3
PRIMARY
Vision Satisfaction
8.7; 8.6
PRIMARY
Lens Centration
62; 63; 1; 0; 0; 0
PRIMARY
Conjunctival Staining
0.4; 0.6
PRIMARY
Smoothness
8.7; 9.1
PRIMARY
Clean Feeling
8.7; 8.9
PRIMARY
Lens Hydrated
8.3; 8.5
PRIMARY
Lens Wettability
8.4; 8.5

Eligibility Criteria

Inclusion Criteria

A person is eligible for inclusion in the study if he/she:

  • Is between 18 and 40 years of age (inclusive)
  • Has read, understood and signed the information consent letter
  • Has had a self-reported eye exam in the last two years
  • Is a spherical soft contact lens wearer
  • Has a contact lens prescription that fits within the available parameters of the study lenses
  • Has a spectacle cylinder no greater than 0.75D (Diopters) in each eye
  • Can achieve best corrected spectacle distance visual acuity of 20/25 (0.10 logMAR) or better in each eye
  • Can achieve a distance visual acuity of 20/30 (0.18 logMAR) or better in each eye with the study contact lenses
  • Has clear corneas and no active ocular disease
  • Is willing and anticipated to be able to comply with the wear schedule (8 hours per day; 5 days a week of lens wear)
  • Is willing and able to follow instructions and maintain the appointment schedule

Exclusion Criteria

A person will be excluded from the study if he/she:

  • Has a history of not achieving comfortable CL (Contact Lens) wear (defined as 5 days per week; >8 hours/day)
  • Is currently wearing senofilcon C (2 weeks lens), senofilcon A 1-Day, senofilcon C (monthly lens) or enfilcon A contact lenses
  • Is habitually using rewetting/ lubricating eye drops more than once per day
  • Presents with clinically significant anterior segment abnormalities
  • Presents with ocular or systemic disease or need of medications which might interfere with contact lens wear
  • Presents with slit lamp findings that would contraindicate contact lens wear such as:
  • Pathological dry eye or associated findings
  • Significant pterygium, pinguecula, or corneal scars within the visual axis
  • Neovascularization > 0.75 mm in from of the limbus
  • Giant papillary conjunctivitis (GCP) worse than grade 1
  • Anterior uveitis or iritis (or history in past year)
  • Seborrheic eczema of eyelid region, Seborrheic conjunctivitis
  • History of corneal ulcers or fungal infections
  • Poor personal hygiene
  • Has a known history of corneal hypoesthesia (reduced corneal sensitivity)
  • Has aphakia, keratoconus or a highly irregular cornea
  • Has presbyopia or has dependence on spectacles for near work over the contact lenses
  • Has undergone corneal refractive surgery
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02956460). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search